Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Entegris Inc., 3 years.
Entegris Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 12, 2025 | AbbVie Inc. | Option exercise | +42,370 | $54.86 | $2,324,418 |
| Aug 12, 2025 | AbbVie Inc. | Open-market sale | −42,370 | $198.42 | $8,407,055 |
| Apr 23, 2025 | Entegris Inc. | Grant or award | +2,897 | — | — |
| Feb 28, 2025 | AbbVie Inc. | Shares withheld for tax | −17,056 | $205.02 | $3,496,821 |
| Feb 13, 2025 | AbbVie Inc. | Grant or award | +17,986 | — | — |
| Feb 13, 2025 | AbbVie Inc. | Grant or award | +7,378 | — | — |
| Feb 13, 2025 | AbbVie Inc. | Grant or award | +6,060 | — | — |
| Feb 13, 2025 | AbbVie Inc. | Grant or award | +7,074 | — | — |
| Sep 24, 2024 | AbbVie Inc. | Gift | −25,630 | — | — |
| Apr 24, 2024 | Entegris Inc. | Grant or award | +1,643 | — | — |
| Feb 28, 2024 | AbbVie Inc. | Shares withheld for tax | −23,966 | $178.99 | $4,289,674 |
| Feb 21, 2024 | AbbVie Inc. | Option exercise | +52,870 | $58.88 | $3,112,986 |
| Feb 21, 2024 | AbbVie Inc. | Open-market sale | −52,870 | $173.71 | $9,184,048 |
| Feb 15, 2024 | AbbVie Inc. | Grant or award | +32,097 | — | — |
| Feb 15, 2024 | AbbVie Inc. | Grant or award | +8,558 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.